Joseph Konowiecki Sells 25,000 Shares of Alignment Healthcare (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) EVP Joseph Konowiecki sold 25,000 shares of the business’s stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $24.00, for a total value of $600,000.00. Following the transaction, the executive vice president directly owned 1,103,816 shares of the company’s stock, valued at $26,491,584. This represents a 2.21% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Alignment Healthcare Stock Performance

ALHC opened at $23.80 on Friday. The firm has a market capitalization of $4.92 billion, a P/E ratio of 264.44, a price-to-earnings-growth ratio of 3.24 and a beta of 1.04. The stock’s 50 day moving average price is $18.96 and its two-hundred day moving average price is $19.71. The company has a quick ratio of 1.58, a current ratio of 1.58 and a debt-to-equity ratio of 1.56. Alignment Healthcare, Inc. has a 12-month low of $11.63 and a 12-month high of $24.30.

Alignment Healthcare (NASDAQ:ALHC) last issued its quarterly earnings results on Thursday, April 30th. The company reported $0.05 EPS for the quarter, topping the consensus estimate of $0.01 by $0.04. Alignment Healthcare had a return on equity of 11.50% and a net margin of 0.47%.The company had revenue of $1.24 billion for the quarter, compared to the consensus estimate of $1.22 billion. During the same period in the previous year, the business posted ($0.05) EPS. The company’s revenue for the quarter was up 33.3% on a year-over-year basis. On average, equities analysts forecast that Alignment Healthcare, Inc. will post 0.2 earnings per share for the current year.

Analyst Ratings Changes

Several research firms recently commented on ALHC. Wall Street Zen upgraded shares of Alignment Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. UBS Group boosted their price objective on shares of Alignment Healthcare from $21.00 to $22.00 and gave the stock a “neutral” rating in a report on Friday, May 1st. Weiss Ratings raised shares of Alignment Healthcare from a “sell (d-)” rating to a “hold (c-)” rating in a research report on Thursday, May 7th. Raymond James Financial set a $22.00 target price on Alignment Healthcare in a research report on Thursday, May 7th. Finally, KeyCorp reaffirmed an “overweight” rating on shares of Alignment Healthcare in a report on Wednesday, June 10th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, Alignment Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $24.30.

Institutional Investors Weigh In On Alignment Healthcare

Several institutional investors and hedge funds have recently bought and sold shares of ALHC. Summit Securities Group LLC bought a new position in shares of Alignment Healthcare during the 4th quarter worth about $26,000. Versant Capital Management Inc increased its stake in Alignment Healthcare by 463.3% in the second quarter. Versant Capital Management Inc now owns 1,380 shares of the company’s stock valued at $33,000 after acquiring an additional 1,135 shares during the period. Parallel Advisors LLC increased its stake in Alignment Healthcare by 87.7% in the fourth quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock valued at $33,000 after acquiring an additional 773 shares during the period. Larson Financial Group LLC acquired a new position in Alignment Healthcare in the third quarter worth about $33,000. Finally, First Horizon Corp acquired a new position in Alignment Healthcare in the fourth quarter worth about $39,000. Institutional investors own 86.19% of the company’s stock.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.